|
|
News Breaks
|
February 9, 2010
|
| 11:17 EDT |  | PRX |
| theflyonthewall.com: | Par Pharmaceutical volatility elevated as shares trend lower | | Par Pharmaceutical is recently down 67c to $24.72. On February 5th PRX announced the FDA stated an inability to approve Zuplenz due to an agency wide restriction on foreign travel to India. PRX is expected to report Q4 EPS on February 24. Call option volume of 609 contracts compares to put volume of 1,146 contracts. February put option implied volatility is at 50, March is at 56 , May is at 51; above its 26-week average of 45, according to Track Data, suggesting larger price movement. :theflyonthewall.com |
|
|
News For PRX From The Last 14 Days Check below for free stories on PRX the last two weeks.
There are 2 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 8, 2012
|
| 09:29 EDT |  | PRX |
| theflyonthewall.com: | Intellipharmaceutics targeting 2012 FDA approval of generic Focalin XR | | Intellipharmaceutics' (IPCI) goals for 2012 include: Obtain FDA approval of Intellipharmaceutics' generic version of Focalin XR; File two additional ANDAs with the FDA; Establish additional development/marketing alliances; Schedule a pre-IND meeting with FDA to discuss Rexista oxycodone clinical development plan; Complete manufacturing of clinical batches of Rexista oxycodone; and Initiate Phase I studies using clinical batches of Rexista oxycodone. Note that Intellipharmaceutics' in February the company completed private placement financing, and revenue from the amendment of the existing development and commercialization agreement between the Company and Par Pharmaceutical (PRX) to include additional strengths of Focalin XR generic products. Under the terms of the expanded agreement, Intellipharmaceutics received a cash payment from Par and will continue to receive a share of profits from any future sales of our generic versions of Focalin XR. :theflyonthewall.com |
|
|
February 3, 2012
|
| 06:18 EDT | | PRX |
|
|
|
|
|
Subscribe for More Information